To investigate the correlations between anemia-associated biomarkers and disease severity in patients with chronic liver disease (CLD) and anemia, while exploring potential biomarkers for clinical management.
Key Findings:
Anemia in CLD is associated with disease severity and complications.
Erythropoietin (EPO) levels positively correlated with soluble transferrin receptor (STFR) in macrocytic and normocytic anemia.
Mean corpuscular volume (MCV) correlated positively with MELD and APRI scores.
Total bilirubin (TBIL) showed a positive correlation with FIB-4 scores.
WBC and ferritin were positively correlated.
Various biomarkers were statistically significant across different anemia types.
Interpretation:
Anemia-related biomarkers may assist in evaluating liver function and managing anemia in CLD patients, highlighting the exploratory nature of the study and the need for further validation.
Limitations:
Study involved a relatively small cohort size.
Findings require validation in larger populations to confirm clinical utility.
Lack of diversity in the patient cohort may introduce bias.
Conclusion:
Anemia in chronic liver disease warrants attention, and the study suggests potential biomarkers for better management, pending further research.
